4th Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$640,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Inflation Reduction Act of 2022 implementation Medicaid Drug Rebate Program proposed rule Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; Ensure patient access to appropriate medications by limiting the unnecessary use of utilization management policies, including H.R. 2163/S. 464 the Safe Step Act Policies impacting pharmaceutical development, reimbursement, and patient access and cost Awareness of need for transparency and patient access within the 340B program H.R. 5894/S. 2624 - Labor, Health and Human Services, Education Appropriations, 2024 H.R. 5893/S. 2321 - Commerce, Justice, Science, and Related Agencies Appropriations, 2024 H.R. 4366/S. 2127 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill, 2024 Support FDA efficiency reforms

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS —
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL —
PETER NORMAN —

Contacted: SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4366 (118th), H.R. 5894 (118th), S. 2127 (118th), S. 464 (118th), S. 2321 (118th), H.R. 5893 (118th), H.R. 2163 (118th), S. 2624 (118th)

Alcohol and Drug Abuse ALC

Expand funding and flexibility to address all substance use disorders;

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS —
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL —
PETER NORMAN —

Contacted: Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Executive Office of the President (EOP); Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.